Upexi Balance Sheet Health

Financial Health criteria checks 1/6

Upexi has a total shareholder equity of $25.5M and total debt of $28.1M, which brings its debt-to-equity ratio to 110.5%. Its total assets and total liabilities are $62.2M and $36.7M respectively.

Key information

110.5%

Debt to equity ratio

US$28.14m

Debt

Interest coverage ration/a
CashUS$1.84m
EquityUS$25.46m
Total liabilitiesUS$36.70m
Total assetsUS$62.16m

Recent financial health updates

Recent updates

This Analyst Just Downgraded Their Upexi, Inc. (NASDAQ:UPXI) EPS Forecasts

Feb 17
This Analyst Just Downgraded Their Upexi, Inc. (NASDAQ:UPXI) EPS Forecasts

Upexi, Inc. (NASDAQ:UPXI) Doing What It Can To Lift Shares

Jun 11
Upexi, Inc. (NASDAQ:UPXI) Doing What It Can To Lift Shares

Grove CEO provides company update on sales and beyond

Jul 13

Why Grove's (NASDAQ:GRVI) Earnings Are Weaker Than They Seem

Oct 05
Why Grove's (NASDAQ:GRVI) Earnings Are Weaker Than They Seem

Grove: An Underrated CBD Player

Jul 31

Financial Position Analysis

Short Term Liabilities: UPXI's short term assets ($22.6M) do not cover its short term liabilities ($24.3M).

Long Term Liabilities: UPXI's short term assets ($22.6M) exceed its long term liabilities ($12.4M).


Debt to Equity History and Analysis

Debt Level: UPXI's net debt to equity ratio (103.3%) is considered high.

Reducing Debt: Insufficient data to determine if UPXI's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: UPXI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: UPXI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.3% each year


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.